Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of lymphatic vessel | 6 studies | 44% ± 18% | |
endothelial cell of sinusoid | 4 studies | 48% ± 23% |
Insufficient scRNA-seq data for expression of STAB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1468.11 | 225 / 226 | 7% | 0.18 | 29 / 406 |
spleen | 100% | 24586.48 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 97% | 249.65 | 933 / 966 | 2% | 0.03 | 9 / 527 |
thymus | 94% | 399.53 | 616 / 653 | 2% | 0.07 | 10 / 605 |
uterus | 91% | 106.68 | 155 / 170 | 3% | 0.05 | 12 / 459 |
lung | 85% | 158.45 | 494 / 578 | 8% | 0.14 | 91 / 1155 |
bladder | 86% | 113.05 | 18 / 21 | 3% | 0.04 | 13 / 504 |
esophagus | 85% | 131.79 | 1223 / 1445 | 2% | 0.06 | 4 / 183 |
breast | 68% | 179.55 | 314 / 459 | 5% | 0.11 | 57 / 1118 |
blood vessel | 71% | 86.92 | 950 / 1335 | 0% | 0 | 0 / 0 |
adipose | 67% | 232.17 | 812 / 1204 | 0% | 0 | 0 / 0 |
ovary | 67% | 153.13 | 120 / 180 | 1% | 0.02 | 3 / 430 |
prostate | 55% | 40.82 | 134 / 245 | 0% | 0.01 | 2 / 502 |
stomach | 48% | 52.94 | 173 / 359 | 3% | 0.08 | 10 / 286 |
skin | 45% | 72.55 | 807 / 1809 | 5% | 0.16 | 23 / 472 |
adrenal gland | 35% | 35.00 | 90 / 258 | 0% | 0.00 | 1 / 230 |
heart | 31% | 52.50 | 271 / 861 | 0% | 0 | 0 / 0 |
kidney | 18% | 15.71 | 16 / 89 | 5% | 0.12 | 49 / 901 |
pancreas | 11% | 6.99 | 37 / 328 | 7% | 0.14 | 12 / 178 |
peripheral blood | 12% | 8.94 | 116 / 929 | 0% | 0 | 0 / 0 |
muscle | 11% | 17.77 | 87 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 8% | 0.11 | 6 / 80 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.10 | 2 / 29 |
brain | 0% | 0.21 | 11 / 2642 | 2% | 0.04 | 16 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0007155 | Biological process | cell adhesion |
GO_0006897 | Biological process | endocytosis |
GO_0030214 | Biological process | hyaluronan catabolic process |
GO_0006898 | Biological process | receptor-mediated endocytosis |
GO_0042742 | Biological process | defense response to bacterium |
GO_0030666 | Cellular component | endocytic vesicle membrane |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0015035 | Molecular function | protein-disulfide reductase activity |
GO_0005041 | Molecular function | low-density lipoprotein particle receptor activity |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0005540 | Molecular function | hyaluronic acid binding |
GO_0005044 | Molecular function | scavenger receptor activity |
Gene name | STAB2 |
Protein name | Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)] Alternative protein STAB2 Stabilin 2 |
Synonyms | FEX2 FEEL2 HARE FELL |
Description | FUNCTION: Phosphatidylserine receptor that enhances the engulfment of apoptotic cells. Hyaluronan receptor that binds to and mediates endocytosis of hyaluronic acid (HA). Acts also, in different species, as a primary systemic scavenger receptor for heparin (Hep), chondroitin sulfate (CS), dermatan sulfate (DS), nonglycosaminoglycan (GAG), acetylated low-density lipoprotein (AcLDL), pro-collagen propeptides and advanced glycation end products (AGE). May serve to maintain tissue integrity by supporting extracellular matrix turnover or it may contribute to maintaining fluidity of bodily liquids by resorption of hyaluronan. Counter receptor which plays an important role in lymphocyte recruitment in the hepatic vasculature. Binds to both Gram-positive and Gram-negative bacteria and may play a role in defense against bacterial infection. The proteolytically processed 190 kDa form also functions as an endocytosis receptor for heparin internalization as well as HA and CS. . |
Accessions | H0YHA5 Q8WWQ8 ENST00000549474.1 ENST00000388887.7 H0YIF3 L8E9Z1 ENST00000552777.1 |